Medicine and Dentistry
Disease
100%
Treatment Response
100%
Chronic Obstructive Pulmonary Disease
100%
Airway Obstruction
100%
Salmeterol
100%
Fluticasone Propionate
100%
Adverse Event
50%
Health Status
50%
Treatment Effect
50%
Placebo
25%
Symptom
25%
Randomized Controlled Trial
25%
Combination Therapy
25%
Dyspnea
25%
Fluticasone Propionate Plus Salmeterol
25%
Keyphrases
Treatment Response
100%
Forced Expiratory Volume in 1 Second (FEV1)
100%
Airway Obstruction
100%
Salmeterol
62%
Fluticasone Propionate
62%
Baseline Severity
37%
Adverse Events
25%
Treatment Effect
25%
Severe Disease
25%
Health Status
25%
Lung Function
25%
Mild Disease
25%
Clinical Outcomes
12%
Treatment Difference
12%
Placebo
12%
Active Treatment
12%
Treatment Efficacy
12%
Combination Treatment
12%
Inhaled Corticosteroids
12%
Clinical Benefit
12%
Group Randomized Controlled Trial
12%
Treatment Prediction
12%
Long-acting β2-agonist
12%
Management Decisions
12%
Diary Card
12%
COPD Management
12%
Breathlessness
12%
Response-adapted
12%
Reliability Prediction
12%
Exacerbation Rate
12%
Active Therapy
12%
Neuroscience
Chronic Obstructive Pulmonary Disease
100%
Fluticasone Propionate
100%
Salmeterol
100%
Placebo
25%
Randomized Controlled Trial
25%
Agonist
25%
Dyspnea
25%
Fluticasone Propionate Plus Salmeterol
25%
Biochemistry, Genetics and Molecular Biology
Fluticasone Propionate
100%
Salmeterol
100%
Health Status
40%
Randomized Controlled Trial
20%
Agonist
20%